Derek Archila
Stock Analyst at Wells Fargo
(4.91)
# 239
Out of 4,630 analysts
922
Total ratings
59.4%
Success rate
22.9%
Average return
Main Sectors:
Stocks Rated by Derek Archila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLDX Celldex Therapeutics | Reiterated: Buy | $72 | $41.75 | +72.46% | 23 | Aug 6, 2026 | |
| EXEL Exelixis | Rated: Hold | $35 → $50 | $54.07 | -7.53% | 27 | Aug 6, 2026 | |
| INCY Incyte | Maintained: Hold | $116 | $120.56 | -3.78% | 41 | Aug 6, 2026 | |
| QTTB Q32 Bio | Reiterated: Buy | $66 → $59 | $15.60 | +278.21% | 10 | Aug 6, 2026 | |
| ANNX Annexon | Reiterated: Buy | $27 | $5.41 | +399.08% | 21 | Aug 6, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $116 | $107.52 | +7.89% | 23 | Aug 6, 2026 | |
| ARVN Arvinas | Downgraded: Hold | $15 → $11 | $8.75 | +25.71% | 26 | Aug 5, 2026 | |
| ORIC ORIC Pharmaceuticals | Maintained: Buy | $25 | $13.50 | +85.19% | 13 | Aug 4, 2026 | |
| PYXS Pyxis Oncology | Initiated Coverage: Buy | $12 | $3.73 | +221.72% | 1 | Aug 3, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $30 → $55 | $45.33 | +21.33% | 3 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,291 → $1,350 | $865.04 | +56.06% | 78 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 | $23.59 | +31.41% | 19 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $115.63 | +34.05% | 61 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $25.53 | -2.08% | 24 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $4.64 | +137.07% | 1 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $27.60 | +84.78% | 9 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $38.83 | +23.62% | 12 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $15.88 | +82.62% | 17 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $326 | $255.41 | +27.64% | 44 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $39.95 | +12.64% | 29 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1 | $0.5114 | +95.54% | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $3.73 | +168.10% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 | $7.96 | +314.57% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $84.48 | +16.00% | 6 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.10 | +138.10% | 1 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $79 | $77.33 | +2.16% | 4 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $479 → $376 | $219.20 | +71.53% | 4 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $56 | $64.71 | -13.46% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $81 | $56.61 | +43.08% | 27 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $73 | $73.31 | -0.42% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $30.98 | +226.02% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $90.22 | -65.64% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 → $30 | $25.38 | +18.20% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $2 | $2.79 | n/a | 16 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $23.54 | n/a | 10 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $4.22 | n/a | 17 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $62.91 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $11.16 | $1.37 | n/a | 1 | Dec 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $2.11 | n/a | 11 | Jun 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $0.4908 | n/a | 34 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $8.85 | n/a | 20 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $46.96 | n/a | 27 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $97 | $27.00 | n/a | 15 | May 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $126 → $130 | $510.04 | n/a | 10 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $13.48 | n/a | 20 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $14.36 | n/a | 28 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $34.26 | n/a | 11 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €15.57 → €16.43 | €4.23 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $19 | $4.80 | n/a | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €286.30 → €288.03 | €770.10 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €90.82 → €96.00 | €23.34 | n/a | 2 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €11.00 | €13.66 | n/a | 7 | Sep 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.02 | n/a | 14 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.00 | n/a | 31 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $11.56 | n/a | 12 | Apr 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.001 | n/a | 11 | Mar 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $12.84 | n/a | 6 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $35.36 | n/a | 18 | Feb 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.9167 | n/a | 8 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.43 | n/a | 1 | Oct 3, 2017 |
Celldex Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $72
Current: $41.75
Upside: +72.46%
Exelixis
Aug 6, 2026
Rated: Hold
Price Target: $35 → $50
Current: $54.07
Upside: -7.53%
Incyte
Aug 6, 2026
Maintained: Hold
Price Target: $116
Current: $120.56
Upside: -3.78%
Q32 Bio
Aug 6, 2026
Reiterated: Buy
Price Target: $66 → $59
Current: $15.60
Upside: +278.21%
Annexon
Aug 6, 2026
Reiterated: Buy
Price Target: $27
Current: $5.41
Upside: +399.08%
Kymera Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $116
Current: $107.52
Upside: +7.89%
Arvinas
Aug 5, 2026
Downgraded: Hold
Price Target: $15 → $11
Current: $8.75
Upside: +25.71%
ORIC Pharmaceuticals
Aug 4, 2026
Maintained: Buy
Price Target: $25
Current: $13.50
Upside: +85.19%
Pyxis Oncology
Aug 3, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $3.73
Upside: +221.72%
First Tracks Biotherapeutics
Jul 28, 2026
Reiterated: Buy
Price Target: $30 → $55
Current: $45.33
Upside: +21.33%
Jul 23, 2026
Maintained: Buy
Price Target: $1,291 → $1,350
Current: $865.04
Upside: +56.06%
Jul 20, 2026
Rated: Buy
Price Target: $31
Current: $23.59
Upside: +31.41%
Jul 16, 2026
Rated: Buy
Price Target: $155
Current: $115.63
Upside: +34.05%
Jul 14, 2026
Maintained: Hold
Price Target: $25
Current: $25.53
Upside: -2.08%
Jul 10, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $4.64
Upside: +137.07%
Jul 1, 2026
Reiterated: Buy
Price Target: $51
Current: $27.60
Upside: +84.78%
Jun 29, 2026
Maintained: Buy
Price Target: $48
Current: $38.83
Upside: +23.62%
Jun 24, 2026
Rated: Buy
Price Target: $29
Current: $15.88
Upside: +82.62%
Jun 17, 2026
Maintained: Buy
Price Target: $326
Current: $255.41
Upside: +27.64%
May 21, 2026
Reiterated: Buy
Price Target: $45
Current: $39.95
Upside: +12.64%
May 18, 2026
Rated: Hold
Price Target: $1
Current: $0.5114
Upside: +95.54%
May 13, 2026
Rated: Buy
Price Target: $10
Current: $3.73
Upside: +168.10%
May 12, 2026
Rated: Buy
Price Target: $33
Current: $7.96
Upside: +314.57%
May 9, 2026
Reiterated: Buy
Price Target: $98
Current: $84.48
Upside: +16.00%
Mar 19, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $2.10
Upside: +138.10%
Mar 2, 2026
Maintained: Buy
Price Target: $78 → $79
Current: $77.33
Upside: +2.16%
Jan 20, 2026
Maintained: Hold
Price Target: $479 → $376
Current: $219.20
Upside: +71.53%
Dec 16, 2025
Maintained: Sell
Price Target: $56
Current: $64.71
Upside: -13.46%
Dec 16, 2025
Maintained: Buy
Price Target: $51 → $81
Current: $56.61
Upside: +43.08%
Oct 17, 2025
Maintained: Buy
Price Target: $73
Current: $73.31
Upside: -0.42%
Oct 17, 2025
Maintained: Buy
Price Target: $101
Current: $30.98
Upside: +226.02%
Oct 17, 2025
Maintained: Buy
Price Target: $31
Current: $90.22
Upside: -65.64%
Aug 12, 2025
Maintained: Hold
Price Target: $40 → $30
Current: $25.38
Upside: +18.20%
Aug 8, 2025
Maintained: Hold
Price Target: $3 → $2
Current: $2.79
Upside: n/a
Aug 7, 2025
Maintained: Hold
Price Target: $14
Current: $23.54
Upside: n/a
Aug 6, 2025
Maintained: Hold
Price Target: $6 → $5
Current: $4.22
Upside: n/a
Dec 6, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $62.91
Upside: n/a
Dec 6, 2021
Initiated Coverage: Sell
Price Target: $11.16
Current: $1.37
Upside: n/a
Jun 13, 2021
Rated: Buy
Price Target: $12
Current: $2.11
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $27
Current: $0.4908
Upside: n/a
May 13, 2021
Reiterated: Hold
Price Target: $3
Current: $8.85
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $30
Current: $46.96
Upside: n/a
May 9, 2021
Reiterated: Hold
Price Target: $96 → $97
Current: $27.00
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: $126 → $130
Current: $510.04
Upside: n/a
May 3, 2021
Reiterated: Hold
Price Target: $7 → $6
Current: $13.48
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $6
Current: $14.36
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $13
Current: $34.26
Upside: n/a
Mar 5, 2021
Maintained: Buy
Price Target: €15.57 → €16.43
Current: €4.23
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $18 → $19
Current: $4.80
Upside: n/a
Mar 4, 2021
Maintained: Hold
Price Target: €286.30 → €288.03
Current: €770.10
Upside: n/a
Feb 19, 2021
Maintained: Hold
Price Target: €90.82 → €96.00
Current: €23.34
Upside: n/a
Sep 30, 2020
Reiterated: Buy
Price Target: €11.00
Current: €13.66
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $25.02
Upside: n/a
Jul 10, 2020
Rated: Hold
Price Target: n/a
Current: $5.00
Upside: n/a
Apr 2, 2018
Reiterated: Buy
Price Target: $13
Current: $11.56
Upside: n/a
Mar 22, 2018
Maintained: Buy
Price Target: n/a
Current: $0.001
Upside: n/a
Mar 5, 2018
Reiterated: Buy
Price Target: $98
Current: $12.84
Upside: n/a
Feb 8, 2018
Rated: Hold
Price Target: n/a
Current: $35.36
Upside: n/a
Nov 9, 2017
Maintained: Hold
Price Target: n/a
Current: $0.9167
Upside: n/a
Oct 3, 2017
Maintained: Hold
Price Target: n/a
Current: $16.43
Upside: n/a